Lung cancer-reacting human recombinant antibody AE6F4: Potential usefulness in the sputum cytodiagnosis

Human Antibodies

Volumn 7, Issue 1, 1996, Pages 27-36

  Shoji, Masahiro ^a   Kawamoto, Seiji ^b   Seki, Kiyohiko ^c   Teruya, Kiichiro ^a   Setoguchi, Yuko ^a   Mochizuki, Katsumi ^a   Kato, Masatoshi ^a   Hashizume, Shuichi ^a   Hanagiri, Takeshi ^d   Yoshimatsu, Takashi ^d   Nakanishi, Kozo ^d   Yasumoto, Kosei ^d   Nagashima, Akira ^e   Nakahashi, Hisashi ^f   Suzuki, Tatsuo ^g   Imai, Tadaaki ^h   Shirahata, Sanetaka ^b   Nomoto, Kikuo ^b   Murakami, Hiroki ^b  

^a 2 1 1 Shimosueyoshi   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^f MATSUYAMA RED CROSS HOSPITAL   (Japan)

^g KITASATO INSTITUTE HOSPITAL   (Japan)

^h KITASATO UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Baby hamster kidney cells; Diagnostics; Human monoclonal antibody; Lung cancer; Recombinant antibody

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M;

ANIMAL CELL; ARTICLE; CELL STRAIN BHK; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SPUTUM CYTODIAGNOSIS; TISSUE SECTION;

14-3-3 PROTEINS; ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; CARCINOMA, SQUAMOUS CELL; CELL LINE; CRICETINAE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; PLASMIDS; PROTEINS; RECOMBINANT PROTEINS; SPUTUM; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; TYROSINE 3-MONOOXYGENASE;

EID: 0029956617     PISSN: 10932607     EISSN: 1875869X     Source Type: Journal    
DOI: 10.3233/HAB-1996-7104     Document Type: Article

References (47)

1. Silverberg E. Cancer statistics, 1985. CA-A Cancer J Clinic 1985; 35: 19
2. Wynder EL, Hiyama T. Comparative epidemiology of cancer in the United States and Japan: Preventive implications. In: Kurihara M, Aoki K, Miller RW, Muir CS, eds. Gann Monograph on Cancer Research No. 33. New York: Plenum, 1987
3. Soube T, Suzuki T, Naruke T. The Japanese Lung Cancer Screening Research Group. Efficacy of lung cancer screening; Comparison of results from a case-control study and a survival analysis. Jpn J Cancer Res 1992; 83: 424
4. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, Bernatz PE, Payne WS, Pairolero PC, Bergstralh EJ. Screening for lung cancer. Cancer 1991; 67: 1155
5. Mulshine JL, Linnoila Rl, Jensen SM, Magnani JL, Tockman MS, Gupta PK, Scott FS, Avis 1, Quinn K, Birrer MJ, Treston AM, Cuttitta F. Rational targets for the early detection of lung cancer. J Natl Cancer Inst Monographs 1992; 13: 183
6. Soda H, Tomita H, Kohno S, Oka M. Limitation of annual screening chest radiography for the diagnosis of lung cancer. Cancer 1993; 72: 2341
7. Tockman MS, Gupta PK, Myers JD, Frost JK, Baylin SB, Gold EB, Chase AM, Wilkinson PH, Mulshine JL. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: A new approach to early lung cancer detection. J Clin Oncol 1988; 6: 1685
8. Saccomanno G, Archer VE, Auerbach O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 1974; 133: 256
9. Shoji M, Kawamoto S, Sato S, Kamei M, Kato M, Hashizume S, Seki K, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K, Murakami H. Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients. Hum Antibod Hybridomas 1994; 5: 116
10. Shoji M, Kawamoto S, Setoguchi Y, Mochizuki K, Honjoh T, Kato M, Hashizume S, Hanagiri T, Yoshimatsu T, Nakanishi K, Yasumoto K, Nagashima A, Nakahashi H, Suzuki T, Imai T, Nomoto K, Murakami H. The 14-3-3 protein as the antigen for lung cancer associated human monoclonal antibody AE6F4. Hum Antibod Hybridomas 1994; 5: 123
11. Aitken A, Collinge DB, van Heusden BPH, Isobe T, Roseboom PH, Rosenfeld G, Soil J. 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins. Trends Biochem Sci 1992; 17: 498
12. Freed E, Symons M, Macdonald SG, McCormick F, Ruggieri R. Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. Science 1994; 265: 1713
13. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT. Activation of Raf-1 by 14-3-3 proteins. Nature 1994; 371: 612
14. Burnett KG, Hayden JM, Hernandez R, Waldron KM, McRoberts NJ, Oh EH. Radiolabeled human antibodies that localize breast cancer in Vivo: Selecting antibodies for clinical applications. In: Strelkauskas AJ, ed. Human Hybridomas, New York: Marcel Dekker, 1987
15. Steis RG, Carrassquillo JA, McCabe R, Bookman MA, Reynolds JC, Larson SM, Smith II JW, Clark JW, Dailey V, Vecchio SD, Shuke N, Pinsky CM, Urba WJ, Haspel M, Perentesis P, Paris B, Longo DL, Hanna Jr MG. Toxicity, immunogenicity, and tumor radioimmunodetecting ability of two human monoclonal antibodies in patients with metastatic colorectal carcinoma.J Clin Oncol 1990; 8: 476
16. Jain RK, Baxter LT. Mechanisms of heterogenous distribution of monoclonal antibodies and other macromolecules in tumors: Significance of elevated interstitial pressure. Cancer Res 1988; 48: 7022
17. Barth WF, Wochner RD, Waldmann TA, Fahey JL. Metabolism of human gamma macroglobulins. J Clin Invest 1964; 43: 1036
18. Seki K, Kawahara H, Tachibana H, et al. Cloning and expression of the human immunoglobulin gene coding human monoclonal antibody AE6F4 reactive to cancer. Submitted
19. Yano T, Teruya K, Shirahata S, Watanabe J, Osada K, Tachibana H, Ohashi H, Kim E-H, Murakami H. Ras oncogene enhances theproduction of a recombinant protein regulated by the cytomegalovirus promoter in BHK-21 cells. Cytotechnology 1994; 16: 167
20. Teruya K, Shirahata S, Yano T, Seki H, Tachibana H, Ohashi H, Murakami H. Secretory cell immunoscreening assay - A highly sensitive screening method for secretory cells. Anal Biochem 1993; 214: 468
21. Grasso A, Roda G, Hogue-Angeletti RA, Moore BW, Perez VJ. Preparation and properties of the brain specific protein 14-3-2. Brain Res 1977; 124: 497
22. Laemmli UK. Cleavage of structural proteins during assembly of bacteriophage-T4. Nature 1970; 227: 680
23. Oakley BR, Kirsch DR, Morris NR. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980; 105: 361
24. Debinski W, Karlsson B, Lindholm L, Siegall CB, Willingham MC, FitzGerald D, Pastan I. Monoclonal antibody C242-Pseudomonas Exotoxin A. J Clinic Invest 1992; 90: 405
25. Ishikawa E, Hashida S, Kohno T, Tanaka K. Methods for enzyme labeling of antigens, antibbdies and their fragments. In: Ngo TT, ed. Nonisotopic Immunoassay. New York: Plenum, 1988
26. Liu Y-C, Kawagishi M, Mikayama T, Inagaki Y, Takeuchi T, Ohashi H. Processing of a fusion protein by endoprotease in COS-1 cells for secretion of mature peptide by a chimeric expression vector. Proc Natl Acad Sci USA 1993; 90: 8957
27. Kjeldsen TB, Rasmussen BB, Rose C, Zeuthen J. Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients. Cancer Res 1988; 48: 3208
28. Haspel MV, McCabe RP, Pomato N, Janesch NJ, Knowlton JV, Peters LC, Hoover HC Jr, Hanna MG Jr. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients. Cancer Res 1985; 45: 3951
29. Olsson L. Human monoclonal antibodies in experimental cancer research. JNCI 1985; 75: 397
30. Glassy MC. Immortalization of human lymphocytes from a tumor involved lymph node. Cancer Res 1987; 47: 5181
31. Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ. Cell-surface antigens of melanoma recognized by human monoclonal antibodies. Proc Natl Acad Sci USA 1987; 84: 2416
32. Campbell AM, Whitford P, Leake RE. Human monoclonal antibodies and monoclonal antibody multispecificity. Br J Cancer 1987; 56: 709
33. Lloyd KO, Old LJ. Human monoclonal antibodies to glyco-lipids and other carbohydrate antigens: Dissection of the humoral immune response in cancer patients. Cancer Res 1989;
34. Glassy MC. Production methods for generating human monoclonal antibodies. Hum Antibod Hybridomas 1993; 4: 154
35. Irie RF, Sze LL, Saxton RE. Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. Proc Natl Acad Sci USA 1982; 79: 5666
36. Cote RJ, Morrissey DM, Houghton AN, Beattie Jr EJ, Oettgen HF, Old LJ. Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci USA 1983; 80: 2026
37. Ho M-K, Geist C, Murray J, Kato K, DeLellis R, Wolfe H, Carney W, Rabin H, Durda P. Distribution and immunochemical characterization of a keratin-like antigen in epithelial tumors using mouse and human monoclonal antibodies. Cancer Res 1988; 48: 4969
38. Sikora K, Alderson T, Nethersell A, Smedley H. Tumor localization by human monoclonal antibodies. Med Oncol Tumor Pharmaother 1985; 2: 77
39. Strelkauskas AJ, Lofton C, Aldenderfer PH. Human monoclonal antibody: 2. Simultaneous expression of IgG and IgM, with similar binding specificities. Hybridomas 1987; 6: 479
40. Ditzel H, Rasmussen JW, Erb K, Jensenius JC. Tumor localization and pharmacokinetics of iodine-125 human monoclonal IgM antibody (COU-1) and its monomeric and half-monomeric fragments analyzed in nude mice grafted with human tumor. Eur JNuclMed 1992; 19: 409
41. Ditzel H, Erb K, Leslie G, Jensenius JC. Preparation of antigen binding monomeric and half-monomeric fragments from human monoclonal IgM antibodies against colorectal cancer-associated antigens. Hum Antibod Hybridomas 1993; 4: 86
42. Komori S, Yamasaki N, Shigeta M, Isojima S, Watanabe T. Production of heavy-chain class-switch variants of human monoclonal antibody by recombinant DNA technology. Clin Exp Immunol 1988; 71: 508
43. Giissow D, Seemann G. Humanization of monoclonal antibodies. Methods Enzymol 1991; 203: 99
44. Benber E, Woof JM, Atkin JD, Barker MD, Bebbington CR, Burton DR. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture. Hum Antibod Hybridomas 1993; 4: 74
45. Winkelhake JL, Nicolson GL. Aglycosylantibody: Effects of exoglycosidase treatments on autochthonous antibody survival time in the circulation. J Biol Chem 1976; 251: 1074
46. Koide N, Nose M, Muramatsu T. Recognition of IgG by Fc receptor and complement: Effects of glycosidase digestion. Biochem Biophys Res Commun 1977; 75: 838
47. Nose M, Wigzell H. Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci USA 1983; 80: 6632